| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Lunzhi Dai | |
| Zhixin Tian | |||
| Yanqiu Gong | |||
| Suideng Qin | |||
| P2860 | cites work | A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 |
| Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors | Q24337334 | ||
| Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry | Q24561920 | ||
| EUROCarbDB: An open-access platform for glycoinformatics | Q24602364 | ||
| The HIV glycan shield as a target for broadly neutralizing antibodies | Q26786540 | ||
| N-linked sugar-regulated protein folding and quality control in the ER | Q26827318 | ||
| Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography-Mass Spectrometry | Q27024150 | ||
| Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry | Q28204943 | ||
| Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications | Q28215287 | ||
| New type of linkage between a carbohydrate and a protein: C-glycosylation of a specific tryptophan residue in human RNase Us | Q28239833 | ||
| Lookup peaks: a hybrid of de novo sequencing and database search for protein identification by tandem mass spectrometry | Q28284555 | ||
| Glycosylation sites and site-specific glycosylation in human Tamm-Horsfall glycoprotein | Q28293520 | ||
| Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp | Q28299555 | ||
| Structure and inhibition of the SARS coronavirus envelope protein ion channel | Q28475712 | ||
| Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search | Q28731567 | ||
| UniCarbKB: building a knowledge platform for glycoproteomics | Q30050744 | ||
| Effect of glycosylation on protein folding: a close look at thermodynamic stabilization | Q30157663 | ||
| Genetic Predisposition To Acquire a Polybasic Cleavage Site for Highly Pathogenic Avian Influenza Virus Hemagglutinin. | Q30378750 | ||
| GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research. | Q30482956 | ||
| Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells | Q109525390 | ||
| Isolation and quantification of N-glycans from immunoglobulin G antibodies for quantitative glycosylation analysis | Q109649598 | ||
| Effectiveness of an Inactivated SARS-CoV-2 Vaccine | Q109649600 | ||
| The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2 | Q109649601 | ||
| MaxDIA enables library-based and library-free data-independent acquisition proteomics | Q109649603 | ||
| Lentil lectin derived from exhibit broad antiviral activities against SARS-CoV-2 variants | Q109649604 | ||
| StrucGP: de novo structural sequencing of site-specific N-glycan on glycoproteins using a modularization strategy | Q109649605 | ||
| The Importance of Glycans of Viral and Host Proteins in Enveloped Virus Infection | Q109649606 | ||
| Hydrophilic interaction/cation-exchange chromatography for glycopeptide enrichment by using a modified strong-cation exchange material | Q109649607 | ||
| O‐glycosylation of the novel SARS‐CoV‐2 coronavirus spike protein influences furin cleavage | Q109649646 | ||
| Structural analysis of glycoprotein sialylation – part II: LC-MS based detection | Q109649648 | ||
| Recent advances in hydrophilic interaction liquid interaction chromatography materials for glycopeptide enrichment and glycan separation | Q109649649 | ||
| Protein C-mannosylation: facts and questions | Q109649651 | ||
| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Q109649652 | ||
| COVID antibody treatments show promise for preventing severe disease | Q109649653 | ||
| Low Levels of Natural Anti-α-N-Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19 | Q109649655 | ||
| Anti-CoVid19 plasmid DNA vaccine induces a potent immune response in rodents by Pyro-drive Jet Injector intradermal inoculation | Q109649656 | ||
| Expression, purification, and characterization of highly active endo-α-N-acetylgalactosaminidases expressed by silkworm-baculovirus expression system | Q109649657 | ||
| Methods to improve quantitative glycoprotein coverage from bottom‐up LC‐MS data | Q109649658 | ||
| Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies | Q109649664 | ||
| Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 | Q109649665 | ||
| A glycan gate controls opening of the SARS-CoV-2 spike protein | Q109649666 | ||
| Comprehensive O-Glycosylation Analysis of the SARS-CoV-2 Spike Protein with Biomimetic Trp-Arg Materials | Q109649667 | ||
| Towards structure-focused glycoproteomics | Q109649668 | ||
| GproDIA enables data-independent acquisition glycoproteomics with comprehensive statistical control | Q109649670 | ||
| Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation | Q109649671 | ||
| Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant | Q109649672 | ||
| Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival | Q109649677 | ||
| In-House Packed Porous Graphitic Carbon Columns for Liquid Chromatography-Mass Spectrometry Analysis of Glycans | Q109649678 | ||
| Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial | Q109649679 | ||
| Structural O-Glycoform Heterogeneity of the SARS-CoV-2 Spike Protein Receptor-Binding Domain Revealed by Top-Down Mass Spectrometry | Q109649681 | ||
| A weak COPI binding motif in the cytoplasmic tail of SARS-CoV-2 spike glycoprotein is necessary for its cleavage, glycosylation, and localization | Q109649682 | ||
| O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins | Q109649683 | ||
| Extensive heterogeneity of glycopeptides in plasma revealed by deep glycoproteomic analysis using size-exclusion chromatography | Q109649684 | ||
| O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an "O-Follow-N" rule | Q109649685 | ||
| Middle-down approach: a choice to sequence and characterize proteins/proteomes by mass spectrometry | Q109649686 | ||
| S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study | Q109649691 | ||
| Precise, Fast and Comprehensive Analysis of Intact Glycopeptides and Monosaccharide-Modifications with pGlyco3 | Q109649692 | ||
| Site-Specific N- and O-Glycosylation Analysis of Human Plasma Fibronectin | Q109649693 | ||
| Site-Specific O-Glycosylation Analysis by Liquid Chromatography–Mass Spectrometry with Electron-Transfer/Higher-Energy Collisional Dissociation | Q109649694 | ||
| Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike | Q109649695 | ||
| COVID-19: Why does disease severity vary among individuals? | Q109649697 | ||
| Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination | Q109649698 | ||
| Structural identification of N-glycan isomers using logically derived sequence tandem mass spectrometry | Q109649721 | ||
| Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sites | Q109649722 | ||
| Stereoelectronic effects in stabilizing protein-N-glycan interactions revealed by experiment and machine learning | Q109649723 | ||
| MS‐based glycomics and glycoproteomics methods enabling isomeric characterization | Q109649724 | ||
| Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection | Q109649725 | ||
| SARS-CoV-2 variants of concern are emerging in India | Q109649726 | ||
| Mucin-type O-glycosylation Landscapes of SARS-CoV-2 Spike Proteins | Q109649727 | ||
| Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome. | Q38211893 | ||
| Accessory proteins of SARS-CoV and other coronaviruses | Q38226293 | ||
| Advances in mass spectrometry driven O-glycoproteomics. | Q38256892 | ||
| Electron capture dissociation, electron detachment dissociation and infrared multiphoton dissociation of sucrose octasulfate | Q38259215 | ||
| Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans | Q38291673 | ||
| The roles of direct recognition by animal lectins in antiviral immunity and viral pathogenesis. | Q38301311 | ||
| Engaging challenges in glycoproteomics: recent advances in MS-based glycopeptide analysis | Q38307330 | ||
| Automatic and rapid identification of glycopeptides by nano-UPLC-LTQ-FT-MS and proteomic search engine. | Q38384461 | ||
| Combining high-energy C-trap dissociation and electron transfer dissociation for protein O-GlcNAc modification site assignment | Q38403960 | ||
| UniCarbKB: putting the pieces together for glycomics research | Q38421228 | ||
| Viral glycoproteins: biological role and application in diagnosis | Q38543883 | ||
| Glycosylation in cancer: mechanisms and clinical implications | Q38569702 | ||
| Proteome-wide analysis of N-glycosylation stoichiometry using SWATH technology. | Q38606097 | ||
| Liquid chromatography-tandem mass spectrometry-based fragmentation analysis of glycopeptides | Q38701314 | ||
| Sequential fragment ion filtering and endoglycosidase-assisted identification of intact glycopeptides | Q38713941 | ||
| Glycoproteomics: A Balance between High-Throughput and In-Depth Analysis. | Q38773369 | ||
| Online coupling of hydrophilic interaction/strong cation exchange/reversed-phase liquid chromatography with porous graphitic carbon liquid chromatography for simultaneous proteomics and N-glycomics analysis | Q38835921 | ||
| Tandem mass spectral libraries of peptides and their roles in proteomics research | Q38893673 | ||
| Reversed-phase separation methods for glycan analysis | Q39020352 | ||
| Recent Advances in the Analysis of Complex Glycoproteins. | Q39096219 | ||
| Characterization of isomeric glycan structures by LC-MS/MS. | Q39215799 | ||
| A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing | Q39244694 | ||
| Databases and Associated Tools for Glycomics and Glycoproteomics. | Q39289132 | ||
| Lectin-carbohydrate interactions: implications for the development of new anticancer agents | Q39330648 | ||
| Glycoproteins | Q39887513 | ||
| Defining Natural Antibodies | Q40097746 | ||
| Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication | Q40260580 | ||
| Improvement of the glycoproteomic toolbox with the discovery of a unique C-terminal cleavage specificity of flavastacin for N-glycosylated asparagine | Q41201334 | ||
| MAGIC: an automated N-linked glycoprotein identification tool using a Y1-ion pattern matching algorithm and in silico MS² approach | Q41514465 | ||
| Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. | Q41861879 | ||
| Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. | Q41935096 | ||
| Supplemental activation method for high-efficiency electron-transfer dissociation of doubly protonated peptide precursors | Q42028472 | ||
| MERS coronavirus envelope protein has a single transmembrane domain that forms pentameric ion channels | Q42158066 | ||
| Tandem mass spectrometry of ribonuclease A and B: N-linked glycosylation site analysis of whole protein ions | Q42170636 | ||
| An adaptive workflow coupled with Random Forest algorithm to identify intact N-glycopeptides detected from mass spectrometry | Q42232278 | ||
| Characterization of intact N- and O-linked glycopeptides using higher energy collisional dissociation | Q42279981 | ||
| Development of a novel method for analyzing collagen O-glycosylations by hydrazide chemistry | Q42323099 | ||
| Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campy | Q42589849 | ||
| Cysteine S-linked N-acetylglucosamine (S-GlcNAcylation), A New Post-translational Modification in Mammals | Q42687789 | ||
| Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. | Q43050786 | ||
| "Glyco-peakfinder"--de novo composition analysis of glycoconjugates | Q30483643 | ||
| Glycoproteomics based on tandem mass spectrometry of glycopeptides | Q30827600 | ||
| A review of methods for interpretation of glycopeptide tandem mass spectral data. | Q31028719 | ||
| UniCarbKB: New database features for integrating glycan structure abundance, compositional glycoproteomics data, and disease associations | Q31052596 | ||
| Differentiating structural isomers of sialylated glycans by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass spectrometry | Q33237440 | ||
| Analysis of protein glycosylation by mass spectrometry | Q33288503 | ||
| Separation-based glycoprofiling approaches using fluorescent labels | Q33300242 | ||
| To b or not to b: the ongoing saga of peptide b ions | Q33425350 | ||
| The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome | Q33447457 | ||
| Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis | Q33553636 | ||
| Utilizing ion-pairing hydrophilic interaction chromatography solid phase extraction for efficient glycopeptide enrichment in glycoproteomics | Q33599995 | ||
| DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysis | Q33602039 | ||
| Tools for Studying Glycans: Recent Advances in Chemoenzymatic Glycan Labeling | Q33793649 | ||
| Biological significance of complex N-glycans in plants and their impact on plant physiology | Q33928774 | ||
| Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy | Q34005185 | ||
| Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds | Q34131204 | ||
| O-Glycosylation of the N-terminal region of the serine-rich adhesin Srr1 of Streptococcus agalactiae explored by mass spectrometry. | Q34157621 | ||
| GlycoSuiteDB: a curated relational database of glycoprotein glycan structures and their biological sources. 2003 update | Q34169553 | ||
| Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. | Q34173762 | ||
| Glycosylation and the immune system | Q34195578 | ||
| N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. | Q34264310 | ||
| GlycoSuiteDB: a new curated relational database of glycoprotein glycan structures and their biological sources | Q34315781 | ||
| Coronaviruses: an overview of their replication and pathogenesis. | Q34464697 | ||
| CE-MS for the analysis of intact proteins 2010-2012. | Q34480662 | ||
| The Hydrophobic Domain of Infectious Bronchitis Virus E Protein Alters the Host Secretory Pathway and Is Important for Release of Infectious Virus | Q34485343 | ||
| GlyTouCan 1.0--The international glycan structure repository | Q34498371 | ||
| GlycoPep Detector: a tool for assigning mass spectrometry data of N-linked glycopeptides on the basis of their electron transfer dissociation spectra | Q34627486 | ||
| Higher-energy C-trap dissociation for peptide modification analysis. | Q34667664 | ||
| Multiple enzyme approach for the characterization of glycan modifications on the C-terminus of the intestinal MUC2mucin. | Q34669466 | ||
| Novel endo-alpha-N-acetylgalactosaminidases with broader substrate specificity | Q34797534 | ||
| Quantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease | Q35085189 | ||
| A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome | Q35140579 | ||
| A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1 | Q35242303 | ||
| The sialic acid binding activity of the S protein facilitates infection by porcine transmissible gastroenteritis coronavirus | Q35248622 | ||
| A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles | Q71543377 | ||
| Simple separation of isomeric sialylated N-glycopeptides by a zwitterionic type of hydrophilic interaction chromatography | Q79415804 | ||
| GlycoPep DB: a tool for glycopeptide analysis using a "Smart Search" | Q79768632 | ||
| Glycoprotein characterization combining intact protein and glycan analysis by capillary electrophoresis-electrospray ionization-mass spectrometry | Q80030419 | ||
| The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis | Q80080632 | ||
| A method to the madness of N-glycan complexity? | Q80121573 | ||
| Molecular interactions in the assembly of coronaviruses | Q81155962 | ||
| Comparison of ultrafiltration units for proteomic and N-glycoproteomic analysis by the filter-aided sample preparation method | Q82819329 | ||
| Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides | Q83511731 | ||
| Elucidation of glycoprotein structures by unspecific proteolysis and direct nanoESI mass spectrometric analysis of ZIC-HILIC-enriched glycopeptides | Q83732785 | ||
| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 | ||
| Strong cation exchange chromatography for analysis of sialylated glycopeptides | Q84170732 | ||
| Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion | Q84315378 | ||
| Structural basis for human coronavirus attachment to sialic acid receptors | Q84315449 | ||
| A pneumonia outbreak associated with a new coronavirus of probable bat origin | Q84367633 | ||
| Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 | ||
| Enrichment of glycopeptides for glycan structure and attachment site identification | Q84742777 | ||
| A new coronavirus associated with human respiratory disease in China | Q84956787 | ||
| Use of boronic acid nanoparticles in glycoprotein enrichment | Q85849305 | ||
| Site-Specific Protein N- and O-Glycosylation Analysis by a C18-Porous Graphitized Carbon-Liquid Chromatography-Electrospray Ionization Mass Spectrometry Approach Using Pronase Treated Glycopeptides | Q86623866 | ||
| Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan | Q86729658 | ||
| Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding | Q86735535 | ||
| The proximal origin of SARS-CoV-2 | Q87830056 | ||
| Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | Q87973551 | ||
| Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses | Q88095064 | ||
| Characterization of intact neo-glycoproteins by hydrophilic interaction liquid chromatography | Q88194661 | ||
| SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor | Q88292103 | ||
| Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers | Q88879010 | ||
| The expanding role of mass spectrometry in the field of vaccine development | Q88935087 | ||
| The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2 | Q88977509 | ||
| GlycoStore: a database of retention properties for glycan analysis | Q89088478 | ||
| Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission | Q89490397 | ||
| Quantitative site- and structure-specific N-glycoproteomics characterization of differential N-glycosylation in MCF-7/ADR cancer stem cells | Q89638333 | ||
| Machine Learning in Mass Spectrometric Analysis of DIA Data | Q89726822 | ||
| Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention | Q89855853 | ||
| DIALib: an automated ion library generator for data independent acquisition mass spectrometry analysis of peptides and glycopeptides | Q89912463 | ||
| Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study | Q89916803 | ||
| Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 | Q89927658 | ||
| Responding to Covid-19 - A Once-in-a-Century Pandemic? | Q89934800 | ||
| [Site-specific O-Glycosylation Analysis of Therapeutic Fc-fusion Protein by Mass Spectrometry] | Q90031915 | ||
| Site- and Structure-Specific Quantitative N-Glycoproteomics Using RPLC-pentaHILIC Separation and the Intact N-Glycopeptide Search Engine GPSeeker | Q90091014 | ||
| Flavivirus envelope protein glycosylation: impacts on viral infection and pathogenesis | Q90244931 | ||
| COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis | Q90256670 | ||
| Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 | Q90364285 | ||
| Use of Lectin-based Affinity Techniques in Breast Cancer Glycoproteomics: A Review | Q90386871 | ||
| Glycoprofile Analysis of an Intact Glycoprotein As Inferred by NMR Spectroscopy | Q90403921 | ||
| COVID-19: consider cytokine storm syndromes and immunosuppression | Q90464964 | ||
| Post-translational modifications of coronavirus proteins: roles and function | Q90576842 | ||
| Diagnosing COVID-19: The Disease and Tools for Detection | Q90725229 | ||
| Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics | Q97093633 | ||
| Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era | Q97529927 | ||
| An mRNA Vaccine against SARS-CoV-2 - Preliminary Report | Q97556695 | ||
| COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives | Q97636279 | ||
| Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates | Q98157102 | ||
| A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity | Q98162456 | ||
| The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity | Q98171290 | ||
| ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques | Q98172337 | ||
| Meta-heterogeneity: evaluating and describing the diversity in glycosylation between sites on the same glycoprotein | Q98184006 | ||
| Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 | Q98196753 | ||
| Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation | Q98205399 | ||
| Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies | Q98206188 | ||
| A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2 | Q98209116 | ||
| SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors | Q98241580 | ||
| Iminosugars: a host-targeted approach to combat Flaviviridae infections | Q98243957 | ||
| Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies | Q98390275 | ||
| Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project) | Q98564699 | ||
| SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine | Q98627919 | ||
| Molecular biology of coronaviruses: current knowledge | Q98657379 | ||
| Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding | Q98720898 | ||
| Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Q98720918 | ||
| Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development | Q98730822 | ||
| Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19 | Q98771881 | ||
| Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects | Q98776709 | ||
| Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine | Q98902656 | ||
| Profiling and characterization of SARS-CoV-2 mutants' infectivity and antigenicity | Q98944864 | ||
| Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain | Q98950361 | ||
| Quantitative N-glycoproteomics using stable isotopic diethyl labeling | Q98950715 | ||
| SARS-CoV-2 envelope protein topology in eukaryotic membranes | Q99212334 | ||
| Structural characterization of the N-linked glycans in the receptor binding domain of the SARS-CoV-2 spike protein and their interactions with human lectins using NMR spectroscopy | Q99354950 | ||
| Databases and Bioinformatic Tools for Glycobiology and Glycoproteomics | Q99555821 | ||
| A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics | Q99557041 | ||
| Resolving Isomeric Structures of Native Glycans by Nanoflow Porous Graphitized Carbon Chromatography - Mass Spectrometry | Q99602501 | ||
| Site- and structure-specific characterization of human urinary N-glycoproteome with site-determining and structure-diagnostic product ions | Q99611499 | ||
| SARS-CoV-2 vaccines in development | Q99614554 | ||
| Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis | Q99637395 | ||
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms | Q99710534 | ||
| Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider | Q99711569 | ||
| An epigenetic mechanism underlying chromosome 17p deletion-driven tumorigenesis | Q99726960 | ||
| COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment | Q99727331 | ||
| Molecular Architecture of the SARS-CoV-2 Virus | Q99732182 | ||
| Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction | Q100304376 | ||
| The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication | Q100307488 | ||
| Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity | Q100419312 | ||
| Tn Antigen Expression Contributes to an Immune Suppressive Microenvironment and Drives Tumor Growth in Colorectal Cancer | Q100438131 | ||
| Fast and comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco | Q100455183 | ||
| Characteristics of SARS-CoV-2 and COVID-19 | Q100465248 | ||
| [Glycosylation, Ligand Binding Sites and Antigenic Variations Between Membrane Glycoprotein of COVID-19 and Related Coronaviruses] | Q100518125 | ||
| A systematic review of SARS-CoV-2 vaccine candidates | Q100533622 | ||
| Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit | Q100535368 | ||
| Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry | Q100675925 | ||
| Comparison of Different HILIC Stationary Phases in the Separation of Hemopexin and Immunoglobulin G Glycopeptides and Their Isomers | Q100684842 | ||
| Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins | Q100736867 | ||
| Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity | Q100750024 | ||
| Global view of human protein glycosylation pathways and functions | Q100762161 | ||
| Glycomics and Glycoproteomics: Approaches to Address Isomeric Separation of Glycans and Glycopeptides | Q100938619 | ||
| Use of adenovirus type-5 vectored vaccines: a cautionary tale | Q100940764 | ||
| Exploring lectin-glycan interactions to combat COVID-19: lessons acquired from other enveloped viruses | Q100949631 | ||
| ORF3a mutation associated higher mortality rate in SARS-CoV-2 infection | Q100990136 | ||
| Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration | Q100996455 | ||
| SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response | Q101038989 | ||
| Coronavirus biology and replication: implications for SARS-CoV-2 | Q101051357 | ||
| The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens | Q101053375 | ||
| Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2 | Q101147151 | ||
| Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein | Q101210696 | ||
| O-Pair Search with MetaMorpheus for O-glycopeptide characterization | Q101237623 | ||
| Coronavirus Proteins as Ion Channels: Current and Potential Research | Q101403573 | ||
| The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET | Q101403930 | ||
| Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers | Q101574529 | ||
| SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo | Q102053711 | ||
| The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and retention of the Spike protein, allowing assembly of virus-like particles | Q102335432 | ||
| N-Glycan Modification in Covid-19 Pathophysiology: In vitro Structural Changes with Limited Functional Effects | Q103014144 | ||
| SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication | Q103027612 | ||
| Cytokine Storm | Q103829219 | ||
| Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity | Q104070007 | ||
| SugarPy facilitates the universal, discovery-driven analysis of intact glycopeptides | Q104482493 | ||
| Viral targets for vaccines against COVID-19 | Q104503058 | ||
| Subtle influence of ACE2 glycan processing on SARS-CoV-2 recognition | Q104503876 | ||
| Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Q104512260 | ||
| The role of Data-Independent Acquisition for Glycoproteomics | Q104609658 | ||
| Glycomics-informed glycoproteomic analysis of site-specific glycosylation for SARS-CoV-2 spike protein | Q104617043 | ||
| Recent advancements in glycoproteomic studies: Glycopeptide enrichment and derivatization, characterization of glycosylation in SARS CoV2, and interacting glycoproteins | Q104738685 | ||
| N- and O-Glycosylation of the SARS-CoV-2 Spike Protein | Q104754984 | ||
| The Role of the SARS-CoV-2 S-Protein Glycosylation in the Interaction of SARS-CoV-2/ACE2 and Immunological Responses | Q107077760 | ||
| Applications of affinity chromatography in proteomics | Q35599747 | ||
| GPQuest: A Spectral Library Matching Algorithm for Site-Specific Assignment of Tandem Mass Spectra to Intact N-glycopeptides. | Q35623058 | ||
| Glycosylation | Q35659693 | ||
| Virus entry: molecular mechanisms and biomedical applications | Q35712985 | ||
| Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme | Q35758573 | ||
| Role of glycosylation in development | Q35799981 | ||
| GlycoPep grader: a web-based utility for assigning the composition of N-linked glycopeptides | Q36074398 | ||
| Direct glycan structure determination of intact N-linked glycopeptides by low-energy collision-induced dissociation tandem mass spectrometry and predicted spectral library searching. | Q36099317 | ||
| Coronavirus E protein forms ion channels with functionally and structurally-involved membrane lipids. | Q36223700 | ||
| Adapting Data-Independent Acquisition for Mass Spectrometry-Based Protein Site-Specific N-Glycosylation Analysis | Q36326392 | ||
| Identification and Validation of Atypical N-Glycosylation Sites | Q36487078 | ||
| The molecular biology of coronaviruses | Q36550910 | ||
| Understanding human glycosylation disorders: biochemistry leads the charge | Q36666135 | ||
| Quantitative glycomics strategies | Q36742414 | ||
| Glycopeptide analysis, recent developments and applications | Q36742418 | ||
| Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells | Q36742425 | ||
| Glycoproteomic analysis of the secretome of human endothelial cells | Q36742432 | ||
| Virus glycosylation: role in virulence and immune interactions | Q36775963 | ||
| Viruses and glycosylation: an overview | Q36821861 | ||
| Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides | Q36915871 | ||
| Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities | Q36957711 | ||
| Human plasma protein N-glycosylation | Q36963945 | ||
| Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus. | Q37065966 | ||
| SWATH-MS Glycoproteomics Reveals Consequences of Defects in the Glycosylation Machinery. | Q37076904 | ||
| Effects of glycosylation on the stability of protein pharmaceuticals | Q37114305 | ||
| Differentiating N-linked glycan structural isomers in metastatic and nonmetastatic tumor cells using sequential mass spectrometry | Q37120207 | ||
| Glycosylation analysis of glycoproteins and proteoglycans using capillary electrophoresis-mass spectrometry strategies | Q37177390 | ||
| Boronic Acid-based approach for separation and immobilization of glycoproteins and its application in sensing | Q37291380 | ||
| Separation, detection and quantitation of peptides by liquid chromatography and capillary electrochromatography | Q37364856 | ||
| Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. | Q37372252 | ||
| Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs | Q37401444 | ||
| N-linked glycosylation enrichment for in-depth cell surface proteomics of diffuse large B-cell lymphoma subtypes | Q37428835 | ||
| Vertebrate protein glycosylation: diversity, synthesis and function | Q37601831 | ||
| A systematic approach to protein glycosylation analysis: a path through the maze | Q37790268 | ||
| Structural basis of receptor recognition by SARS-CoV-2 | Q90738246 | ||
| Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Q90738260 | ||
| COVID-19, ACE2, and the cardiovascular consequences | Q90757948 | ||
| Virology, Epidemiology, Pathogenesis, and Control of COVID-19 | Q90773888 | ||
| COVID-19, SARS and MERS: are they closely related? | Q90799557 | ||
| The role of galectins in virus infection - A systemic literature review | Q90828681 | ||
| Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF) | Q90839124 | ||
| Advances in mass spectrometry-based glycoproteomics | Q91379582 | ||
| Site- and structure-specific quantitative N-glycoproteomics study of differential N-glycosylation in MCF-7 cancer cells | Q91410936 | ||
| Gal-3 is a potential biomarker for spinal cord injury and Gal-3 deficiency attenuates neuroinflammation through ROS/TXNIP/NLRP3 signaling pathway | Q91431725 | ||
| High-throughput Serum N-Glycomics: Method Comparison and Application to Study Rheumatoid Arthritis and Pregnancy-associated Changes | Q91638315 | ||
| SARS-CoV-2 Vaccines: Status Report | Q91662248 | ||
| A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria | Q91723010 | ||
| Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension | Q91776300 | ||
| Natural antibodies - facts known and unknown | Q91871967 | ||
| A New Searching Strategy for the Identification of O-Linked Glycopeptides | Q91887207 | ||
| Mapping human N-linked glycoproteins and glycosylation sites using mass spectrometry | Q91934872 | ||
| Coronaviruses and SARS-COV-2 | Q91953835 | ||
| GlycopeptideGraphMS: Improved Glycopeptide Detection and Identification by Exploiting Graph Theoretical Patterns in Mass and Retention Time | Q91954789 | ||
| Proteomics analysis of site-specific glycoforms by a virtual multistage mass spectrometry method | Q92133207 | ||
| Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer | Q92184158 | ||
| GPSeeker Enables Quantitative Structural N-Glycoproteomics for Site- and Structure-Specific Characterization of Differentially Expressed N-Glycosylation in Hepatocellular Carcinoma | Q92221737 | ||
| Recent advances in glycoinformatic platforms for glycomics and glycoproteomics | Q92235926 | ||
| Glyco-DIA: a method for quantitative O-glycoproteomics with in silico-boosted glycopeptide libraries | Q92432902 | ||
| Advances toward mapping the full extent of protein site-specific O-GalNAc glycosylation that better reflects underlying glycomic complexity | Q92448534 | ||
| Spontaneous Glycan Reattachment Following N-Glycanase Treatment of Influenza and HIV Vaccine Antigens | Q92493535 | ||
| Advances in hydrophilic nanomaterials for glycoproteomics | Q92633404 | ||
| Glycosylation of viral surface proteins probed by mass spectrometry | Q92766714 | ||
| New Energy Setup Strategy for Intact N-Glycopeptides Characterization Using Higher-Energy Collisional Dissociation | Q92848186 | ||
| Post-translational modification of baculovirus-encoded proteins | Q92975253 | ||
| Enzymatic Release of Glycoprotein N-Glycans and Fluorescent Labeling | Q93133579 | ||
| The Architecture of SARS-CoV-2 Transcriptome | Q93208123 | ||
| The trinity of COVID-19: immunity, inflammation and intervention | Q94452368 | ||
| Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships | Q94462993 | ||
| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | Q94470555 | ||
| Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 | Q94503955 | ||
| Site-specific glycan analysis of the SARS-CoV-2 spike | Q94520441 | ||
| Rapid development of an inactivated vaccine candidate for SARS-CoV-2 | Q94589803 | ||
| Cell entry mechanisms of SARS-CoV-2 | Q94589965 | ||
| Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells | Q95262934 | ||
| Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody | Q95300582 | ||
| Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium | Q95304682 | ||
| DNA vaccine protection against SARS-CoV-2 in rhesus macaques | Q95337677 | ||
| Glycoinformatics approach for identifying target positions to inhibit initial binding of SARS-CoV-2 S1 protein to the host cell | Q95605363 | ||
| The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system | Q95645944 | ||
| Low collision energy fragmentation in structure-specific glycoproteomics analysis | Q95646204 | ||
| Optimal Dissociation Methods Differ for N- and O-glycopeptides | Q96160474 | ||
| α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19 | Q96219633 | ||
| Proteolytic Cleavage of the SARS-CoV-2 Spike Protein and the Role of the Novel S1/S2 Site | Q96225931 | ||
| Protein glycosylation analysis by HILIC-LC-MS of Proteinase K-generated N- and O-glycopeptides | Q43133934 | ||
| Synthesis of N-linked glycopeptides on solid support and their evaluation as protease substrates | Q43156979 | ||
| Investigations on the chromatographic behaviour of zwitterionic stationary phases used in hydrophilic interaction chromatography | Q43414844 | ||
| Photodissociation of conformer-selected ubiquitin ions reveals site-specific cis/trans isomerization of proline peptide bonds | Q43624959 | ||
| A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. | Q44978166 | ||
| The GlycanBuilder and GlycoWorkbench glycoinformatics tools: updates and new developments | Q46156566 | ||
| Use of multidimensional lectin affinity chromatography in differential glycoproteomics | Q46462285 | ||
| Structure elucidation of native N- and O-linked glycans by tandem mass spectrometry (tutorial). | Q46614544 | ||
| HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. | Q46808539 | ||
| Analysis of mammalian O-glycopeptides - we have made a good start, but there is a long way to go. | Q46846034 | ||
| Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites | Q46972135 | ||
| Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications. | Q47153267 | ||
| Top-Down Proteomics of Large Proteins up to 223 kDa Enabled by Serial Size Exclusion Chromatography Strategy | Q47220928 | ||
| Accurate phosphorylation site localization using phospho-brackets | Q47348158 | ||
| Large-scale identification and visualization of N-glycans with primary structures using GlySeeker | Q47379081 | ||
| Exploiting the reversible covalent bonding of boronic acids: recognition, sensing, and assembly. | Q47562366 | ||
| Development of a data independent acquisition mass spectrometry workflow to enable glycopeptide analysis without predefined glycan compositional knowledge. | Q47604730 | ||
| Determination of site-specific glycan heterogeneity on glycoproteins | Q47650180 | ||
| Microfluidic Capillary Electrophoresis-Mass Spectrometry for Analysis of Monosaccharides, Oligosaccharides, and Glycopeptides | Q48116778 | ||
| Evaluation of Different N-Glycopeptide Enrichment Methods for N-Glycosylation Sites Mapping in Mouse Brain | Q48592705 | ||
| Glycoprotein Enrichment Analytical Techniques: Advantages and Disadvantages | Q49812897 | ||
| N- and O-glycosylation analysis of human C1-inhibitor reveals extensive mucin-type O-glycosylation | Q49886884 | ||
| Investigation of O-glycosylation heterogeneity of recombinant coagulation factor IX using LC-MS/MS. | Q50049635 | ||
| Efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis. | Q51091942 | ||
| Fast, robust and high-resolution glycosylation profiling of intact monoclonal IgG antibodies using nanoLC-chip-QTOF. | Q51457632 | ||
| Global Aspects of Viral Glycosylation Enveloped viruses/herpesvirus/mass spectrometry/mucin type O-glycosylation/viral glycans. | Q52341713 | ||
| Global site-specific analysis of glycoprotein N-glycan processing. | Q53068939 | ||
| Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. | Q53529803 | ||
| Large-scale assignment of N-glycosylation sites using complementary enzymatic deglycosylation. | Q54297336 | ||
| Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry. | Q55056794 | ||
| Deciphering Protein O-Glycosylation: Solid-Phase Chemoenzymatic Cleavage and Enrichment | Q56349359 | ||
| Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping | Q56898429 | ||
| Intact Human Alpha-Acid Glycoprotein (AGP) Analyzed by ESI-qTOF-MS: Simultaneous Determination of the Glycan Composition of Multiple Glycosylation Sites | Q57181402 | ||
| Rapid phenolic O-glycosylation of small molecules and complex unprotected peptides in aqueous solvent | Q57581070 | ||
| The benefits of hybrid fragmentation methods for glycoproteomics | Q57665965 | ||
| Crosstalk between phosphorylation and O-GlcNAcylation: friend or foe | Q57665970 | ||
| Glycosylation Site Analysis of Human Platelets by Electrostatic Repulsion Hydrophilic Interaction Chromatography | Q57842255 | ||
| Unravelling the Role of O-glycans in Influenza A Virus Infection | Q58608748 | ||
| Chemical Tagging in Mass Spectrometry for Systems Biology | Q58612613 | ||
| Identification and Quantification of Protein Glycosylation | Q58703048 | ||
| Enzymatic Digestion and Mass Spectroscopies of N-Linked Glycans in Lacquer Stellacyanin fromRhus vernicifera | Q59110781 | ||
| Dopant Enriched Nitrogen Gas Combined with Sheathless Capillary Electrophoresis–Electrospray Ionization-Mass Spectrometry for Improved Sensitivity and Repeatability in Glycopeptide Analysis | Q60709652 | ||
| Capturing site-specific heterogeneity with large-scale N-glycoproteome analysis | Q64066959 | ||
| Coronavirus envelope protein: current knowledge | Q64287253 | ||
| Exploitation of glycosylation in enveloped virus pathobiology | Q64359271 | ||
| Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues. | Q64902298 | ||
| Glycosylation in health and disease. | Q64912085 | ||
| Characterizing the selectivity of ER α-glucosidase inhibitors. | Q64916951 | ||
| Glycosylation of lipoprotein lipase in human subcutaneous and omental adipose tissues | Q68233145 | ||
| Lectin affinity chromatography of glycopeptides | Q69076240 | ||
| Glycan analysis by modern instrumental methods | Q37829419 | ||
| From lectin structure to functional glycomics: principles of the sugar code. | Q37860605 | ||
| Stationary and mobile phases in hydrophilic interaction chromatography: a review | Q37866441 | ||
| Strategies for the profiling, characterisation and detailed structural analysis of N-linked oligosaccharides | Q38038071 | ||
| Glycopeptide enrichment and separation for protein glycosylation analysis. | Q38045258 | ||
| N-glycoproteomics: mass spectrometry-based glycosylation site annotation. | Q38048786 | ||
| N-linked protein glycosylation in the ER. | Q38098761 | ||
| The use of sialidase therapy for respiratory viral infections | Q38100493 | ||
| Increasing the α 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer | Q38169157 | ||
| Interaction modes and approaches to glycopeptide and glycoprotein enrichment | Q38171227 | ||
| Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits | Q96230047 | ||
| Cytokine Storm Induced by SARS-CoV-2 | Q96342930 | ||
| Isomeric Separation of N-Glycopeptides Derived from Glycoproteins by Porous Graphitic Carbon (PGC) LC-MS/MS | Q96437772 | ||
| The ORF3a protein of SARS-CoV-2 induces apoptosis in cells | Q96576788 | ||
| Open database searching enables the identification and comparison of bacterial glycoproteomes without defining glycan compositions prior to searching | Q96639231 | ||
| A potential role for Galectin-3 inhibitors in the treatment of COVID-19 | Q96687334 | ||
| Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus | Q96870819 | ||
| Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity | Q107134284 | ||
| Simultaneous enrichment and separation of neutral and sialyl glycopeptides of SARS-CoV-2 spike protein enabled by dual-functionalized Ti-IMAC material | Q107329301 | ||
| Glycosylation is a key in SARS-CoV-2 infection | Q107344131 | ||
| Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells | Q107344366 | ||
| How glycobiology can help us treat and beat the COVID-19 pandemic | Q107349011 | ||
| A COVID-19 Vaccine: Big Strides Come with Big Challenges | Q107349021 | ||
| Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production | Q107349422 | ||
| Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein | Q107377078 | ||
| Glycosylation of SARS-CoV-2: structural and functional insights | Q107466751 | ||
| Assessing Antigen Structural Integrity through Glycosylation Analysis of the SARS-CoV-2 Viral Spike | Q107466804 | ||
| The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2 | Q107473264 | ||
| Heterogeneity of Glycan Processing on Trimeric SARS-CoV-2 Spike Protein Revealed by Charge Detection Mass Spectrometry | Q108105033 | ||
| Quantitative single-cell proteomics as a tool to characterize cellular hierarchies | Q108126951 | ||
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | Q108396862 | ||
| Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 | Q109117104 | ||
| P433 | issue | 1 | |
| P921 | main subject | protein glycosylation | Q14839643 |
| SARS-CoV-2 | Q82069695 | ||
| spike glycoprotein [SARS-CoV-2] | Q87917585 | ||
| Viroporin 3a | Q88200603 | ||
| envelope protein [SARS-CoV-2] | Q88655710 | ||
| membrane protein [SARS-CoV-2] | Q88656821 | ||
| P577 | publication date | 2021-11-15 | |
| P1433 | published in | Signal Transduction and Targeted Therapy | Q108821959 |
| P1476 | title | The glycosylation in SARS-CoV-2 and its receptor ACE2 | |
| P478 | volume | 6 |
| Q101235543 | Maturation of spike protein |
| Q101210482 | Spike glycoprotein of SARS-CoV-2 binds ACE2 on host cell |
Search more.